Affiliation:
1. Department of Medical Microbiology and Immunology, University of Alberta
2. Division of Medical Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, Alberta, Canada
Abstract
An incubation time of 24 h at 35 to 38°C is recommended for the optimal performance of MRSA
Select
(Bio-Rad) chromogenic screening agar. An additional 24 h is required to capture slow-growing methicillin-resistant
Staphylococcus aureus
(MRSA). However, the normal hours of operation for most laboratories cannot reliably accommodate 24-h interpretation intervals. Daily agar plate interpretations are more likely to occur around 18 h and 42 h of incubation, which may compromise the performance of the chromogenic agar and negatively impact patient infection control efforts. In order to validate the importance of stringent incubation times to plate performance, we evaluated MRSA
Select
medium at controlled intervals of 24 and 48 h of incubation, using clinical MRSA-screening swabs. A total of 1,071 MRSA-positive and 2,733 MRSA-negative cultures were selected for analysis. Compared to 48-h-incubation results, the sensitivity and specificity of MRSA
Select
at 24 h were 98.3% and 98.2%, respectively. Only 19 of 1,071 (1.8%) MRSA-positive isolates required 48 h for detection. Holding 24-h negative plates an additional 24 h resulted in the workup of 253 (6.6%) pink, yet non-MRSA, colonies. The 24-h positive and negative predictive values of MRSA
Select
, assuming MRSA prevalences of 1, 5, and 10%, were 35.5 and 99.98%, 74.2 and 99.9%, and 85.9 and 99.8%, respectively. MRSA
Select
medium held for 24-h incubation is a highly sensitive and specific MRSA-screening tool. Further incubation prolongs the turnaround time for results and creates a significant amount of unnecessary work in the laboratory.
Publisher
American Society for Microbiology
Reference13 articles.
1. Ben Nsira, S., M. Dupuis, and R. Leclercq. 2006. Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 27:561-564.
2. Canadian Nosocomial Infection Surveillance Program. 2005. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals—a report update from the Canadian Nosocomial Infection Surveillance Program. Can. Commun. Dis. Rep. 31:33-40.
3. Cherkaoui, A., G. Renzi, P. Francois, and J. Schrenzel. 2007. Comparison of four chromogenic media for culture-based screening of methicillin-resistant Staphylococcus aureus. J. Med. Microbiol. 56:500-503.
4. Performance standards for antimicrobial susceptibility testing; 17th informational supplement M100-S17. 2007
5. Jones, E. M., K. E. Bowker, R. Cooke, R. J. Marshall, D. S. Reeves, and A. P. MacGowan. 1997. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J. Hosp. Infect. 35:59-62.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献